Table 1 Description of ovarian cancer patients participating in the study
Case no. | Histological grade | Clinical stage | Tumour subtype | CA125 (U ml−1) |
|---|---|---|---|---|
6 | 1 | 1a | Endometrioid | 773 |
64 | 1 | 1b | Endometrioid | 786 |
83 | 1 | 1c | Endometrioid | 126 |
106 | 1 | 3c | Mixed | 93 |
164 | 1 | 1b | Endometrioid | 636 |
190 | 1 | 1a | Mucinous | 25 |
198 | 1 | 2c | Endometrioid | 55 |
32 | 2 | 1a | Endometrioid | 302 |
35 | 2 | 3c | Serous | 1200 |
46 | 2 | 4 | Serous | 3457 |
49 | 2 | 3c | Serous | 900 |
110 | 2 | 3c | Serous | 1719 |
121 | 2 | 3c | Serous | 3471 |
123 | 2 | 3b | Mixed | 106 |
129 | 2 | 3c | Mixed | 3823 |
161 | 2 | 1c | Mixed | 698 |
2 | 3 | 3c | Serous | 647 |
3 | 3 | 3c | Serous | 513 |
44 | 3 | 2b | Endometrioid | 165 |
85 | 3 | 1a | Serous | 147 |
88 | 3 | 3c | Serous | 883 |
90 | 3 | 3c | Endometrioid | 659 |
96 | 3 | 3c | Serous | 137 |
108 | 3 | 3c | Serous | 61 |
143 | 3 | 4 | Clear cell | 507 |
146 | 3 | 4 | Serous | 2463 |
153 | 3 | 4 | Serous | 985 |
158 | 3 | 3c | Serous | 287 |
